Selected research
Industry Growth & Trends
Global Fractionated Plasma Products Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Fractionated Plasma Products market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Fractionated Plasma Products is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Fractionated Plasma Products market include Takeda, Weiguang Bio, Tiantan Bio, Hualan Bio, Yuanda Shuyang, Shuanglin Bio, RAAS, Octapharma and Nanyue Bio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Fractionated Plasma Products market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Fractionated Plasma Products market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Fractionated Plasma Products market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Fractionated Plasma Products.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Fractionated Plasma Products market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Fractionated Plasma Products Market by Company
Takeda
Weiguang Bio
Tiantan Bio
Hualan Bio
Yuanda Shuyang
Shuanglin Bio
RAAS
Octapharma
Nanyue Bio
LFB Group
KM Biologics
Kedrion
Grifols
CSL
CBPO
BPL
Boya Bio
Biotest
Fractionated Plasma Products Segment by Type
Coagulation Factor
Immune Globulin
Albumin
Other
Fractionated Plasma Products Segment by Application
Immunology
Hematology
Other
Fractionated Plasma Products Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Fractionated Plasma Products market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Fractionated Plasma Products and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Fractionated Plasma Products.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Fractionated Plasma Products companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Coagulation Factor
- Immune Globulin
- Albumin
- Other
Applications
- Immunology
- Hematology
- Other
Companies covered
- Takeda
- Weiguang Bio
- Tiantan Bio
- Hualan Bio
- Yuanda Shuyang
- Shuanglin Bio
- RAAS
- Octapharma
- Nanyue Bio
- LFB Group
- KM Biologics
- Kedrion
- Grifols
- CSL
- CBPO
- BPL
- Boya Bio
- Biotest
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Fractionated Plasma Products Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Fractionated Plasma Products Market Size by Region (2021-2032)
- 1.4.1 Global Fractionated Plasma Products Market Size by Region (2021-2026)
- 1.4.2 Global Fractionated Plasma Products Market Size by Region (2027-2032)
- 1.5 Key Regions Fractionated Plasma Products Market Size (2021-2032)
- 1.5.1 North America Fractionated Plasma Products Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Fractionated Plasma Products Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Fractionated Plasma Products Market Size Growth Rate (2021-2032)
- 1.5.4 South America Fractionated Plasma Products Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Fractionated Plasma Products Market Size Growth Rate (2021-2032)
2 Fractionated Plasma Products Market by Type
- 2.1 Type Introduction
- 2.1.1 Coagulation Factor
- 2.1.2 Immune Globulin
- 2.1.3 Albumin
- 2.1.4 Other
- 2.2 Global Fractionated Plasma Products Market Size by Type
- 2.2.1 Global Fractionated Plasma Products Market Size Overview by Type (2021-2032)
- 2.2.2 Global Fractionated Plasma Products Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Fractionated Plasma Products Market Size Forecasted by Type (2027-2032)
- 2.3 Global Fractionated Plasma Products Market Size by Regions
- 2.3.1 North America Fractionated Plasma Products Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Fractionated Plasma Products Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Fractionated Plasma Products Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Fractionated Plasma Products Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Fractionated Plasma Products Market Size Breakdown by Type (2021-2026)
3 Fractionated Plasma Products Market by Application
- 3.1 Type Introduction
- 3.1.1 Immunology
- 3.1.2 Hematology
- 3.1.3 Other
- 3.2 Global Fractionated Plasma Products Market Size by Application
- 3.2.1 Global Fractionated Plasma Products Market Size Overview by Application (2021-2032)
- 3.2.2 Global Fractionated Plasma Products Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Fractionated Plasma Products Market Size Forecasted by Application (2027-2032)
- 3.3 Global Fractionated Plasma Products Market Size by Regions
- 3.3.1 North America Fractionated Plasma Products Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Fractionated Plasma Products Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Fractionated Plasma Products Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Fractionated Plasma Products Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Fractionated Plasma Products Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Fractionated Plasma Products Industry Trends
- 4.2 Fractionated Plasma Products Industry Drivers
- 4.3 Fractionated Plasma Products Industry Opportunities and Challenges
- 4.4 Fractionated Plasma Products Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Fractionated Plasma Products Revenue (2021-2026)
- 5.2 Global Fractionated Plasma Products Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Fractionated Plasma Products Key Company Headquarters & Area Served
- 5.4 Global Fractionated Plasma Products Company, Product Type & Application
- 5.5 Global Fractionated Plasma Products Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Fractionated Plasma Products Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Fractionated Plasma Products Players Market Share by Revenue in 2025
- 5.6.3 2025 Fractionated Plasma Products Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Takeda
- 6.1.1 Takeda Company Information
- 6.1.2 Takeda Business Overview
- 6.1.3 Takeda Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Takeda Fractionated Plasma Products Product Portfolio
- 6.1.5 Takeda Recent Developments
- 6.2 Weiguang Bio
- 6.2.1 Weiguang Bio Company Information
- 6.2.2 Weiguang Bio Business Overview
- 6.2.3 Weiguang Bio Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Weiguang Bio Fractionated Plasma Products Product Portfolio
- 6.2.5 Weiguang Bio Recent Developments
- 6.3 Tiantan Bio
- 6.3.1 Tiantan Bio Company Information
- 6.3.2 Tiantan Bio Business Overview
- 6.3.3 Tiantan Bio Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Tiantan Bio Fractionated Plasma Products Product Portfolio
- 6.3.5 Tiantan Bio Recent Developments
- 6.4 Hualan Bio
- 6.4.1 Hualan Bio Company Information
- 6.4.2 Hualan Bio Business Overview
- 6.4.3 Hualan Bio Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Hualan Bio Fractionated Plasma Products Product Portfolio
- 6.4.5 Hualan Bio Recent Developments
- 6.5 Yuanda Shuyang
- 6.5.1 Yuanda Shuyang Company Information
- 6.5.2 Yuanda Shuyang Business Overview
- 6.5.3 Yuanda Shuyang Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Yuanda Shuyang Fractionated Plasma Products Product Portfolio
- 6.5.5 Yuanda Shuyang Recent Developments
- 6.6 Shuanglin Bio
- 6.6.1 Shuanglin Bio Company Information
- 6.6.2 Shuanglin Bio Business Overview
- 6.6.3 Shuanglin Bio Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Shuanglin Bio Fractionated Plasma Products Product Portfolio
- 6.6.5 Shuanglin Bio Recent Developments
- 6.7 RAAS
- 6.7.1 RAAS Company Information
- 6.7.2 RAAS Business Overview
- 6.7.3 RAAS Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 RAAS Fractionated Plasma Products Product Portfolio
- 6.7.5 RAAS Recent Developments
- 6.8 Octapharma
- 6.8.1 Octapharma Company Information
- 6.8.2 Octapharma Business Overview
- 6.8.3 Octapharma Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Octapharma Fractionated Plasma Products Product Portfolio
- 6.8.5 Octapharma Recent Developments
- 6.9 Nanyue Bio
- 6.9.1 Nanyue Bio Company Information
- 6.9.2 Nanyue Bio Business Overview
- 6.9.3 Nanyue Bio Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Nanyue Bio Fractionated Plasma Products Product Portfolio
- 6.9.5 Nanyue Bio Recent Developments
- 6.10 LFB Group
- 6.10.1 LFB Group Company Information
- 6.10.2 LFB Group Business Overview
- 6.10.3 LFB Group Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 LFB Group Fractionated Plasma Products Product Portfolio
- 6.10.5 LFB Group Recent Developments
- 6.11 KM Biologics
- 6.11.1 KM Biologics Company Information
- 6.11.2 KM Biologics Business Overview
- 6.11.3 KM Biologics Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 KM Biologics Fractionated Plasma Products Product Portfolio
- 6.11.5 KM Biologics Recent Developments
- 6.12 Kedrion
- 6.12.1 Kedrion Company Information
- 6.12.2 Kedrion Business Overview
- 6.12.3 Kedrion Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Kedrion Fractionated Plasma Products Product Portfolio
- 6.12.5 Kedrion Recent Developments
- 6.13 Grifols
- 6.13.1 Grifols Company Information
- 6.13.2 Grifols Business Overview
- 6.13.3 Grifols Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Grifols Fractionated Plasma Products Product Portfolio
- 6.13.5 Grifols Recent Developments
- 6.14 CSL
- 6.14.1 CSL Company Information
- 6.14.2 CSL Business Overview
- 6.14.3 CSL Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 CSL Fractionated Plasma Products Product Portfolio
- 6.14.5 CSL Recent Developments
- 6.15 CBPO
- 6.15.1 CBPO Company Information
- 6.15.2 CBPO Business Overview
- 6.15.3 CBPO Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 CBPO Fractionated Plasma Products Product Portfolio
- 6.15.5 CBPO Recent Developments
- 6.16 BPL
- 6.16.1 BPL Company Information
- 6.16.2 BPL Business Overview
- 6.16.3 BPL Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 BPL Fractionated Plasma Products Product Portfolio
- 6.16.5 BPL Recent Developments
- 6.17 Boya Bio
- 6.17.1 Boya Bio Company Information
- 6.17.2 Boya Bio Business Overview
- 6.17.3 Boya Bio Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 Boya Bio Fractionated Plasma Products Product Portfolio
- 6.17.5 Boya Bio Recent Developments
- 6.18 Biotest
- 6.18.1 Biotest Company Information
- 6.18.2 Biotest Business Overview
- 6.18.3 Biotest Fractionated Plasma Products Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Biotest Fractionated Plasma Products Product Portfolio
- 6.18.5 Biotest Recent Developments
7 North America
- 7.1 North America Fractionated Plasma Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Fractionated Plasma Products Market Size by Country (2021-2026)
- 7.3 North America Fractionated Plasma Products Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Fractionated Plasma Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Fractionated Plasma Products Market Size by Country (2021-2026)
- 8.3 Europe Fractionated Plasma Products Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Fractionated Plasma Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Fractionated Plasma Products Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Fractionated Plasma Products Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Fractionated Plasma Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Fractionated Plasma Products Market Size by Country (2021-2026)
- 10.3 South America Fractionated Plasma Products Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Fractionated Plasma Products Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Fractionated Plasma Products Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Fractionated Plasma Products Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst